BRIEF-Hikma Pharma agrees $22.2 mln Egypt deal

LONDON Wed Jan 9, 2013 2:10am EST

Related Topics

LONDON Jan 9 (Reuters) - Hikma Pharmaceuticals PLC : * Hikma pharmaceutical - acquisition * To acquire the egyptian company for pharmaceuticals & chemical industries * will pay cash consideration of EGP 142.4 million upon

closing, or approximately USD 22.2 million * deal adds a portfolio of 35 products in 46 dosage forms and strengths

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.